Trending Now
LATEST ARTICLES
The First Prescription Digital Therapeutic for Anxiety & Depression
Happify Health launched Ensemble, the first and only transdiagnostic prescription digital therapeutic for the treatment of patients who have Major Depressive Disorder (MDD) or...
Beyond Campaigns: Why Strategic Partnerships Are Becoming Pharma Marketing’s Competitive Advantage
Strategic partnerships in pharma are reshaping how companies approach marketing in a rapidly evolving industry. While traditional campaigns once drove awareness and engagement, they...
Is Pharma Losing Control of Its Narrative? What Marketers Must Do in a Data-Driven...
Control over pharma brand messaging is no longer what it used to be. As digital platforms, AI systems, and third-party data channels continue to...
Global Teams, Local Execution: How Pharma Marketers Can Navigate a More Distributed Operating Model
What happens when your marketing team spans five continents, but your audience expects relevance at a local level? That tension is now at the...
The Rise of Unbranded AI Influence: How Pharma Marketers Can Stay Relevant Without Owning...
The growing influence of AI in pharma marketing is rapidly changing how clinicians and patients access drug information. Instead of relying solely on branded...
AI Partnerships Are Reshaping Pharma: What Marketers Need to Know About the New Power...
What happens when pharmaceutical companies no longer just use technology but depend on it to make decisions? That question sits at the center of...
The Portfolio Fragmentation Challenge: How Marketers Can Maintain a Clear Story Amid Constant Acquisitions
What happens when your brand story changes every quarter? For many pharma marketers, that question feels less theoretical and more like a daily reality....
Speed vs Safety: How Pharma Marketers Can Compete in a Faster, More Scrutinized Market
Speed in pharma marketing is no longer just a competitive advantage. It is quickly becoming a necessity. As approvals accelerate and digital channels evolve,...
The Demand–Evidence Gap: What GLP-1 Growth Teaches Pharma Marketers About Responsible Messaging
The rise of GLP-1 therapies has reshaped how people think about chronic disease treatment, but it also highlights a growing tension between pharma demand...
The Algorithmic Gatekeeper: How Pharma Marketers Can Stay Visible in AI-Filtered Channels
AI-driven content optimization in pharma is no longer optional. Today, algorithms decide what healthcare professionals and patients actually see. Think about it like a...
When AI Speaks for Your Brand: What Pharma Marketers Must Do to Stay in...
The risk of AI in pharma compliance is no longer a distant concern. It is happening right now as artificial intelligence tools generate drug-related...
